{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-014246","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2023-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.818678+00:00","generated_at":"2026-06-16T16:23:12.303370+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Cue Biopharma appoints Pamela Garzone to board of directors","bullets":["Pamela Garzone appointed to board effective April 19, 2023, following recommendation of committee.","Received option to purchase 40,000 shares vesting over three years.","Compensation per Director Compensation Policy; standard indemnification agreement.","No reportable transactions or arrangements with other persons."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-014246","json":"https://secwatch.observer/filing/0000950170-23-014246.json","markdown":"https://secwatch.observer/filing/0000950170-23-014246.md","text":"https://secwatch.observer/filing/0000950170-23-014246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000095017023014246/0000950170-23-014246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000095017023014246/cue-20230419.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T16:23:12.303370+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c8eca647b","claim":"Pamela Garzone was appointed as Director at Cue Biopharma, Inc..","evidence_excerpt":"On April 19, 2023, Pamela Garzone was appointed to the board of directors (the “Board”) of Cue Biopharma, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017023014246/0000950170-23-014246-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}